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Context
Combination treatment with intravenous immunoglobu-
lin (IVIG) plus prednisolone, newly designed for children
with severe Kawasaki disease (KD), significantly reduces
coronary artery abnormalities [1]. Prednisolone is admi-
nistered for approximately 20 days in this regimen.
Objective
Our aim was to examine whether adrenal function of
the treated patients is suppressed by glucocorticoid
administration in this regimen.
Design/setting
This was a prospective study at one medical institution.
Patients
We analyzed data from 21 children with KD who were
treated with IVIG plus prednisolone between February
and June, 2012.
Main outcome measures
The main outcome measures were cortisol and ACTH
values in the morning after the cessation of predniso-
lone administration and peak cortisol and ACTH values
at CRH stimulation tests repeated 0, 2, and 6 months
after the treatment.
Results
Morning cortisol and ACTH values after the cessation
of prednisolone treatment were suppressed. Peak corti-
sol values at the first CRH stimulation test ranged from
5.1 to 25.4 mcg/dL and were less than 20 mcg/dL in
17 of 21 patients, but were restored to more than 14.6
mcg/dL in all of them by 6 months after the predniso-
lone treatment. A significant positive correlation was
observed between cortisol values at 09:00 after the pre-
dnisolone treatment and peak cortisol values at the fol-
lowing CRH stimulation test (r = 0.770, p < 0.0001).
Conclusions
Adrenal suppression can occur in a high proportion of
children with KD treated with IVIG plus prednisolone,
despite rather short duration and low administered dose
of glucocorticoids.
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